ReviewIntegrative and comparative biology2025
Beyond Species Richness: The Importance of Phylogenetic Dimensions of Biodiversity in Disease Ecology.
Review in Integrative and comparative biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Contrasting geographic patterns of parasite and hantavirus diversity in the rodent Oligoryzomys longicaudatus (Rodentia, Cricetidae).PLoS neglected tropical diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Biodiversity loss and anthropogenic changes to community composition have profound effects on disease emergence and transmission. These alterations influence disease risk by either amplifying or reducing disease risk, depending on the spatial scale, ecological context, and the indices used to characterize biodiversity and disease risk. We argue that species richness alone is often insufficient and that evolutionary relationships among hosts offer critical and underappreciated insights into disease dynamics. By drawing on recent empirical and theoretical studies, we highlight how phylogenetic approaches can enhance our understanding of the dynamics between biodiversity and disease. Future studies must move beyond descriptive use of phylogenetic diversity and develop mechanistic frameworks that integrate community structure and host evolutionary relationships into transmission processes to better assess disease risk under global change.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.